Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Founded in 2008, Mount Sinai Ventures is the corporate venture capital arm of Mount Sinai Health System. The firm invests in new, existing, and startup healthcare businesses, including ambulatory surgery centers, urgent care centers, management service organizations, and health technology companies. Its mission is to advance breakthroughs that benefit patients and to diversify strategic investment portfolios to enhance Mount Sinai's transition to population health management.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
1 portfolio exit on record.
Portfolio by sector
Health Tech & Life Sciences1
Fintech & Insurtech1
Q&A
- What is Mount Sinai Ventures' most notable exit?
- Mount Sinai Ventures exited Hippo Insurance in August 2021 through a public offering on the NYSE, with a valuation of $5 billion. Hippo Insurance had raised $550 million in capital.
- Which sectors does Mount Sinai Ventures focus on for its portfolio companies?
- Mount Sinai Ventures has portfolio companies in Health Tech & Life Sciences and Fintech & Insurtech.
- Can you name some of Mount Sinai Ventures' portfolio companies?
- Mount Sinai Ventures' portfolio includes Hippo Insurance, an AI-based property insurance company, and Novotalk, which provides digital therapy for speech disorders.
- What is Mount Sinai Ventures' investment activity like in terms of funding stages?
- Mount Sinai Ventures has participated in both Seed and B Round funding stages.
- When did Mount Sinai Ventures make its most recent investments?
- Mount Sinai Ventures made investments in January 2018 and October 2018.
- What is the primary sector for Mount Sinai Ventures' exits?
- Mount Sinai Ventures' exits are primarily in the Fintech & Insurtech sector.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2008 |
|---|